LabCorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation

Author's Avatar
Jul 30, 2020
Article's Main Image

LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced plans to create a program to offer total antibody testing at no charge through the patient’s doctor in support of increased blood plasma donations for use as a possible COVID-19 treatment.